Please fill out the form below and we will gladly respond as soon as possible.
US WorldMeds® announced that the U.S. Food and Drug Administration has granted full approval to TECELRA® (afamitresgene autoleucel), with an expanded indication that now includes eligible patients as young as 12 years old. The therapy, which received its original accelerated approval in August 2024, remains the first and only FDA-approved engineered T-cell therapy for a […]
A case report published in Frontiers in Oncology by Miyazaki, Oike, and colleagues at Niigata University Graduate School of Medical and Dental Sciences, Japan, documents a rare synovial sarcoma presentation that defeated every standard diagnostic test – and delayed correct treatment by over three years. The case carries urgent lessons for patients, advocates, and clinicians […]
